Stock Groups

EU says mRNA vaccine booster may be given to those with weak immunity By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: Mauricette, an elderly French woman of 78 years, is greeted by health professionals at Rene-Muret, in Sevran. This was after she had received her first Pfizer-BioNTech vaccine against the coronavirus (COVID-19).

(Reuters) – On Monday, the EU drug regulator stated that people suffering from a severely weakened immune system could be administered a third dose COVID-19 vaccinations. Pfizer (NYSE: Moderna (NASDAQ: ) Minimum 28 days from the second dose.

Although countries come to different conclusions as to who is eligible, the long-awaited guidance was issued after several EU member state launched their booster campaigns. The repeat shot will be given six months later than the original two-dose course.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]